Sporanox

Sporanox is a brand name of itraconazole, approved by the FDA in the following formulation(s):

SPORANOX (itraconazole - capsule; oral)

• 
  Manufacturer: JANSSEN PHARMS
  
  Approval date: September 11, 1992
  
  Strength(s): 100MG ^[RLD][AB]

SPORANOX (itraconazole - solution; oral)

• 
  Manufacturer: JANSSEN PHARMS
  
  Approval date: February 21, 1997
  
  Strength(s): 10MG/ML ^[RLD]

Has a generic version of Sporanox been approved?

A generic version of Sporanox has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Sporanox and have been approved by the FDA:

itraconazole capsule; oral

• 
  Manufacturer: SANDOZ
  
  Approval date: May 28, 2004
  
  Strength(s): 100MG ^[AB]

Note: No generic formulation of the following product is available.

• itraconazole - solution; oral

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Sporanox. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Beads having a core coated with an antifungal and a polymer
  Patent 5,633,015
  Issued: May 27, 1997
  Inventor(s): Gilis; Paul M. V. & De Conde ; Valentin F. V. & Vandecruys; Roger P. G.
  The present invention is concerned with beads comprising a 25-30 mesh core, a coating of a hydrophilic polymer and an antifungal agent, and a seal outer coating layer; pharmaceutical dosage forms comprising said beads and a method of preparing said beads. Preferred antifungal agents are lipophilic azole antifungals, such as itraconazole and saperconazole.
  
  Patent expiration dates:
  
  
  • May 27, 2014
    
  
  



• 
  Oral formulations on an antifungal
  Patent 5,707,975
  Issued: January 13, 1998
  Inventor(s): Fran.cedilla.ois; Marc Karel Jozef & Dries; Willy Maria Albert Carlo
  Assignee(s): Janssen Pharmaceutica, N.V.
  The present invention concerns a formulation for oral administration comprising an antifungal, a sufficient amount of a cyclodextrin or a derivative thereof, an aqueous acidic medium as bulk liquid carrier and an alcoholic co-solvent Addition of one or more pharmaceutically acceptable sweeteners and one or more pharmaceutically acceptable flavors thereto yields palatable oral formulations. A process of preparing such formulations and pharmaceutical dosage forms comprising said formulations.
  
  Patent expiration dates:
  
  
  • January 13, 2015
    
  
  



• 
  Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
  Patent 6,407,079
  Issued: June 18, 2002
  Inventor(s): Bernd W.; Müller & Ulrich; Brauns
  Assignee(s): Janssen Pharmaceutica N.V.
  Pharmaceutical compositions comprising inclusion compounds of sparingly water-soluble or water-instable drugs with &bgr;-cyclodextrin ethers or &bgr;-cyclodextrin esters and process for the preparation thereof.
  
  Patent expiration dates:
  
  
  • June 18, 2019
    
  
  

See also...

• Sporanox Consumer Information (Drugs.com)
• Sporanox Consumer Information (Wolters Kluwer)
• Sporanox Capsules Consumer Information (Wolters Kluwer)
• Sporanox Solution Consumer Information (Wolters Kluwer)
• Sporanox Consumer Information (Cerner Multum)
• Sporanox Advanced Consumer Information (Micromedex)
• Sporanox AHFS DI Monographs (ASHP)
• Itraconazole Consumer Information (Wolters Kluwer)
• Itraconazole Capsules Consumer Information (Wolters Kluwer)
• Itraconazole Solution Consumer Information (Wolters Kluwer)
• Itraconazole Consumer Information (Cerner Multum)
• Itraconazole Advanced Consumer Information (Micromedex)
• Itraconazole AHFS DI Monographs (ASHP)